Table 3

Concentration-dependent PRB inhibition of VPA glucuronidation

PRBVmaxKm3-a
μg/ml μg/min/mg of protein μg/ml
00.80  ± 0.06173  ± 29
7.140.98  ± 0.09273  ± 59
14.31.09  ± 0.13371  ± 91
1430.75  ± 0.12342  ± 87
7140.88  ± 0.15461  ± 124
28500.76  ± 0.37584  ± 278

Data are expressed as mean ± S.D. (n = 3) based on five VPA concentrations (7.2–721 μg/ml) per preparaton.

  • 3-a  Significantly different across PRB treatment; P = .0194, one-way ANOVA.